Portugal 3D Imaging Market Analysis Report 2022 to 2030

Portugal 3D Imaging Market Analysis

$ 3999

Portugal's 3D imaging market is projected to grow from $0.09 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by the rising frequency of chronic diseases in Portugal and innovations in 3D Imaging technology. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & RI-TE - Radiation Imaging Technologies.

ID: IN10PTDH001 CATEGORY: Digital Health GEOGRAPHY: Portugal AUTHOR: Vidhi Upadhyay

Buy Now

Portugal 3D Imaging Market Executive Summary

Portugal's 3D imaging market is projected to grow from $0.09 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. Portugal has around 200 hospitals that are well-recognized by both worldwide and European criteria. The cost of healthcare in Portugal is quite reasonable. These are supported by general taxation and worker payments through the social security system. Residents of Portugal must pay a modest fraction of their medical expenses, generally a few euros for each appointment. Health spending increased by 12.2% in 2021, hitting 11.2% of GDP (0.7% point more than in 2020), the highest level in the available record that began in 2000.

In Portugal, surgical planning and guiding is a prominent use of 3D Imaging. 3D imaging technology may be used to produce precise models of a patient's anatomy, assisting surgeons in the planning and preparation of difficult treatments such as spine surgery, joint replacements, and craniofacial reconstructions. One of the main applications is in diagnostic imaging, including computed tomography (CT) and magnetic resonance imaging (MRI) scans. 3D Imaging technology can be employed in medical education and research, in addition to clinical implications.

In April 2022, Unilabs and GE Healthcare joined forces to bring cutting-edge radiology equipment and imaging services to Portugal. Affidea Group in July 2022, acquired advanced diagnostics and outpatient services providers Clínica Nuno Álvares and Clínica de Santa Mafalda.

portugal 3D imaging market analysis

Market Dynamics

Market Growth Drivers

Several reasons are driving the 3D Imaging industry in Portugal. There is a growing demand in the country for modern medical technologies as healthcare practitioners aim to improve patient outcomes and quality of service. The frequency of chronic illnesses including cancer, cardiovascular disease, and neurological disorders is increasing, necessitating precise and thorough imaging for diagnosis and therapy planning. Moreover, innovations in 3D Imaging technology, such as enhanced resolution, speed, and automation, are making these imaging modalities more accessible and cost-effective. Finally, the growing use of telemedicine and remote healthcare services is opening up new avenues for 3D Imaging providers to reach patients in rural or underserved locations.

Market Restraints

The high cost of 3D Imaging equipment and software may prevent smaller healthcare practitioners and hospitals with restricted resources from using these technologies. Second, there may be a scarcity of competent people trained to operate and analyze 3D Imaging data, slowing the adoption of these devices. Concerns about data privacy and security may also pose difficulties, particularly when 3D Imaging creates vast volumes of sensitive patient data. Finally, the COVID-19 pandemic had caused havoc in the healthcare business, potentially delaying investments and the adoption of innovative technology such as 3D Imaging.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Sectra AB
RI-TE - Radiation Imaging Technologies (PRT)

Notable Deals

November 2022, GE Healthcare, and MediView XR, Inc., a leading clinical augmented reality med-tech company, revealed their collaboration to incorporate imaging techniques into mixed reality solutions via the OmnifyXRTM Interventional Suite System

February 2022, FUJIFILM VisualSonics, a global producer of ultra-high-frequency (UHF) ultrasound imaging systems, collaborated with PIUR IMAGING, the European leader in tomographic ultrasound imaging, to deliver UHF, three-dimensional (3D) ultrasound imaging technology to physicians and researchers. This technical innovation aids clinical research in the evaluation of defects in a variety of applications such as dermatology, neurology, vascular, and MSK.

Healthcare Policies and Regulatory Landscape

Several bodies in Portugal manage the authority, regulation, and reimbursement of 3D Imaging. The Ministry of Health is in charge of developing medical device rules and regulations, including 3D Imaging technology. INFARMED (Autoridade Nacional do Medicamento e Produtos de Sade / National Authority of Medicines and Health Products) is the Portuguese Regulatory Authority (RA), an agency within the Portuguese Ministry of Health that evaluates, authorizes, regulates, and supervises the market, regardless of the origin of the devices, ensuring public health protection.

Reimbursement Scenario

In Portugal, the National Health Service (SNS) covers the cost of medical treatments and procedures, including those using 3D Imaging. However, reimbursement regulations for these technologies may differ based on the imaging modality and medical justification.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Portugal 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.